Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

20.0%

1 terminated out of 5 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

3Total
P 1 (1)
P 2 (1)
P 4 (1)

Trial Status

Recruiting2
Unknown1
Terminated1
Not Yet Recruiting1

Clinical Trials (5)

Showing 5 of 5 trials
NCT06929468Not Yet RecruitingPrimary

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

NCT06885411RecruitingPrimary

Ototoxicity in Patients With MoM Hip Bearings

NCT04226456Phase 4TerminatedPrimary

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

NCT04291209Phase 1UnknownPrimary

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

NCT05129748Phase 2RecruitingPrimary

Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy

Showing all 5 trials

Research Network

Activity Timeline